Objective: To study the incidence, associated risk factors and outcomes of thrombocytopenia in a group of high risk neonates admitted to the Neonatal Intensive Care Unit (NICU) of a tertiary care teaching hospital.
Introduction
A healthy neonate, even a preterm, has the same mean platelet count as adults and a platelet count less than 150,000/cu mm is defined as thrombocytopenia 1 . Thrombocytopenia is present in 1-5% of newborns at birth and severe thrombocytopenia in 0.1-0.5% 2 . Thrombocytopenia develops in 22-35% of all babies admitted to neonatal intensive care units (NICUs), in up to 50% of those admitted to NICUs who require intensive care and in 50% of sick preterms 3 . The various grades of thrombocytopenia are: mild (100,000-150,000 per cu mm), moderate (50,000-100,000 per cu mm) and severe (<50,000 per cu mm). Some authors categorize platelet counts less than 30,000 per cu mm as severe thrombocytopenia 4 .
The causes are best differentiated by the time of presentation into fetal, early (<3 days of age) and late onset (3-28 days) 4 . Common fetal causes of thrombocytopenia are alloimmune, congenital infections, aneuploidy and autoimmune 4 . Early onset thrombocytopenia is usually secondary to placental insufficiency [e.g. intrauterine growth retardation (IUGR), diabetes, perinatal asphyxia, disseminated intravascular coagulation (DIC), alloimmunity and autoimmunity, congenital infections, thrombosis, bone marrow replacement, metabolic diseases and congenital/inherited syndromes] 4 . Late onset thrombocytopenia is often secondary to sepsis or necrotising enterocolitis. Thrombocytopenia not explained by other causes, may indicate an underlying thromboembolic event 4 . The most common cause of severe thrombocytopenia in neonates is immune thrombocytopenia from antiplatelet antibodies across placenta 5 . Low platelet count in an otherwise healthy term newborn is due to neonatal alloimmune thrombocytopenia (NAIT) until proven otherwise 4 .
The only treatment available for neonatal thrombocytopenia, except for immune thrombocytopenia, is platelet transfusion 6 . Neonates should receive 10-15 ml/kg of cytomegalovirus safe or leukoreduced platelets and they are at increased risk for transfusion-associated graft versus host disease 7 . There are limited Indian prospective studies to identify risk factors associated with neonatal thrombocytopenia and its clinical outcome.
Objective
To study the incidence, associated risk factors and outcomes of thrombocytopenia in a group of high risk neonates admitted to the Neonatal Intensive Care Unit (NICU) of a tertiary care teaching hospital.
Method
A prospective observational study was carried out at Level III NICU of Sri Guru Ram Dass Institute of Medical Sciences and Research, Amritsar from January to July 2013, a period of six months. A total of 100 high risk neonates (intramural + extramural) admitted to the NICU during this period formed the study group. The inclusion criteria were:
• Frank bleed.
• Brown or red respiratory tract aspirate.
• A neonate suddenly presenting with decline in haemoglobin and bulging fontanelle / lethargy/ tone changes / pupillary changes suggesting intraventricular haemorrhage (IVH) in a preterm baby, subarachnoid haemorrhage (SAH) or subdural haemorrhage (SDH) in a term baby.
• Positive maternal history viz. pregnancy induced hypertension (PIH), leaking per vagina, infections (Dengue, TORCH etc.), drug history, diabetes, systemic lupus erythematosus (SLE), idiopathic thrombocytopenic purpura (ITP), bleeding per vagina (BPV).
• Positive family history of thrombocytopenia (in any sibling / bleeding tendency in the family).
• Prematurity, intrauterine growth retardation (IUGR) / small for gestational age (SGA), twin deliveries.
• Neonates presenting with jaundice.
• Neonates with a history of perinatal asphyxia • Neonates presenting with respiratory distress syndrome (RDS), necrotising enterocolitis (NEC) or meconium aspiration syndrome (MAS).
• Neonates presenting with refusal to feed, fever and lethargy or involvement of more than two organ systems suggestive of septicaemia (or sclerema).
• Neonates with positive blood cultures, peripheral blood films suggestive of sepsis, higher total leucocyte counts than recommended for age, raised C-reactive protein (CRP), positive cerebrospinal fluid (CSF) study, conjugated hyperbilirubinaemia • Syndromic babies (Down, Turner etc.) and neonates with congenital malformations and congenital diseases.
• Neonates undergoing any surgical interventions.
• Neonates receiving mechanical ventilation and neonates with central line in situ • Sick newborns and with multiple NICU admissions.
The cases were enrolled consecutively after taking written, informed consent from one or both parents after completely explaining the study details to them. Babies of parents who refused to sign the consent form were excluded from the study.
Gestational age was calculated by obstetrical estimate according to last menstrual period, combined with ultrasound and/or Ballard scoring if required. Enrolled neonates were observed prospectively and platelet counts were done at presentation and subsequently as and when required. Platelet count of less than 150,000/cu mm was taken as the cut off point for determining thrombocytopenia. All neonates who fulfilled the criteria for admission were shifted to the special care neonatal unit for observation and management. Platelet count was done daily or repeated earlier in sick neonates. Treatment consisted of transfusion of random donor platelet concentrates (RDPCs), when required. Platelet transfusion guidelines were followed 4 . After completion of data collection, statistical analysis (Chi square test) was done to find out the association of the risk factors with neonatal thrombocytopenia.
Results
In our NICU, the incidence of thrombocytopenia was 55% among the high risk neonates. Mild thrombocytopenia (100,000-150,000 per cu mm) was observed in 16.4% neonates, moderate thrombocytopenia (50,000-100,000 per cu mm) in 36.4% and severe thrombocytopenia (<50,000 per cu mm) in 47.5%. Early onset thrombocytopenia (<3 days of age) was seen in 51% and late onset thrombocytopenia (3- Table 14 .
Of the 55 high risk neonates with thrombocytopenia 21 (38%) received platelet transfusions and of them 11 (52%) showed improved platelet counts, 4 (19%) died, 4 (19%) left against medical advice and 2 (10%) were discharged on request. All 5 babies with IVH were less than 28 weeks in gestation. The 11 bleeding neonates either bled frankly through feeding tube, oral cavity, endotracheal tube and/or nose or had frank haematuria.
Discussion
Up to 30% of NICU patients develop thrombocytopenia at some time during hospital admission 3, 8, 9 . In our NICU 55% of high risk neonates developed thrombocytopenia. Platelet transfusions are frequently given to NICU patients and may result in unnecessary transfusions 10 . Improved guidelines are required for safe lower limits for platelet transfusions in stable and sick neonates, effective platelet transfusion protocols in sick neonates and improved therapy for conditions precipitating thrombocytopenia 10 . Bhat YR et al showed that 57.7% of thrombocytopenia was associated with the male gender 11 . In our study population there were 84% males but only 53.5% of males developed thrombocytopenia compared to 62.5% of females. Thus gender was not significantly associated with thrombocytopenia (P=0.511). Beiner ME et al showed that 31% of preterm babies developed thrombocytopenia 12 . In our study 58.2% preterm babies developed thrombocytopenia. However, 51.1% term babies also developed thrombocytopenia. Thus the association of prematurity with thrombocytopenia was not significant (P=0.480). Christensen RD et al observed thrombocytopenia in 73% of the extremely low birth weight (ELBW) population, being more common in the neonates with birth weight <800g 13 . In our study 100% of ELBW babies had thrombocytopenia. However, low birth weight as a whole was not significantly associated with thrombocytopenia (P=0.471) Gupta AK et al found no relation between platelet count and type of delivery 14 . Nursen B et al demonstrated a relationship between the severity of thrombocytopenia and the severity and staging of hypoxic ischaemic encephalopathy 15 . In our study perinatal asphyxia was significantly associated with thrombocytopenia (P=0.015). Maruyama H et al found growth restriction to be a significantly independent risk factor for thrombocytopenia 16 . In our study SGA/IUGR was significantly associated with thrombocytopenia (P=0.008). Bhat YR et al observed that 36% of neonates born to mothers with PIH had thrombocytopenia 17 . In our study maternal risk factors were significantly associated with thrombocytopenia (P=0.006).
Gupta AK et al observed that 81.5% of septic neonates developed low platelet counts 14 . In our study sepsis was significantly associated with thrombocytopenia (P=0.016). Arif SH et al observed that Klebsiella was the most commonly isolated organism 18 . In our study the commonest organism isolated was Staphylococcus aureus with Klebsiella taking second place. Bacterial infection causes damage to vascular endothelial lining, thus accelerating adhesion, destruction, and removal of platelets. Viral infection increases platelet destruction due to loss of sialic acid from platelet membrane, increases platelet aggregation, and decreased production from infected marrow 19 . Sepsis also causes DIC, immune-mediated destruction, and decreased production of platelets from infected marrow 20 . Gupta AK et al observed that 43% of thrombocytopenic neonates had respiratory risk factors 14 . In our study respiratory risk factors were significantly associated with thrombocytopenia (P=0.035).
Burrows RF et al showed that thrombocytopenia occurs in twin pregnancy due to plasma dilution 21 . In our study twin delivery was not significantly associated with thrombocytopenia (P=0.542). Jeremiah ZA et al showed that 19.7% of the babies with low platelet counts had neonatal jaundice as the risk factor 22 . In our study neonatal jaundice was not significantly associated with thrombocytopenia (P=0.315). Roberts I et al observed that 90% of cases of late onset thrombocytopenia were due to necrotizing enterocolitis 6 . In our study NEC was not significantly associated with thrombocytopenia (P=0.058). Roberts I et al showed that babies born with certain congenital syndromes have late onset thrombocytopenia 6 . In our study congenital defects/syndromes were not significantly associated with thrombocytopenia (P=0.315).
Von Lindern JS et al found that 12% of babies with neonatal thrombocytopenia developed IVH 23 . In our study 5 (9.1%) high risk babies with neonatal thrombocytopenia developed IVH and all 5 were less than 28 weeks in gestation. This is understandable since the germinal matrix lacks a fibronectin layer in preterm babies. Bonifacio L et al observed that mucocutaneous bleeding complicated 18.4% of cases with severe and late-onset thrombocytopenia 24 . In our study 11 (20%) of high risk neonates with thrombocytopenia developed bleeding. Von Lindern JS et al showed that out of all included neonates with thrombocytopenia, 29% received a platelet transfusion 23 . In our study 21 (38%) high risk neonates with thrombocytopenia received platelet transfusions.
Platelet transfusions are frequently given to NICU patients with severe thrombocytopenia but no study has assessed whether this is clinically appropriate. Although the widely used liberal triggers for neonatal platelet transfusion reflect available guidelines and represent cautious ('safe') haemostatic practice, they are likely to result in unnecessary transfusion for a significant number of NICU patients. Improved practice requires definition of a safe lower limit for platelet count in stable neonates; effective platelet transfusion strategies for sick neonates; and improved therapies for conditions precipitating severe thrombocytopenia.
Conclusions
• Thrombocytopenia occurred in 55% neonates admitted to NICU.
• Perinatal asphyxia, maternal risk factors, respiratory risk factors, sepsis and SGA/IUGR were significantly associated with thrombocytopenia.
